Helicobacter pylori in First Nations and recent immigrant populations in Canada

被引:32
作者
Jones, Nicola L. [1 ,2 ,3 ]
Chiba, Naoki [4 ,5 ]
Fallone, Carlo [6 ]
Thomson, Alan [7 ]
Hunt, Richard [4 ,8 ]
Jacobson, Kevan [9 ,10 ]
Goodman, Karen [11 ]
机构
[1] Hosp Sick Children, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Toronto, ON M5G 1X8, Canada
[2] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada
[3] Univ Toronto, Dept Physiol, Toronto, ON, Canada
[4] McMaster Univ, Div Gastroenterol, Hamilton, ON, Canada
[5] Guelph Gen Hosp, Guelph, ON, Canada
[6] McGill Univ, Ctr Hlth, Div Gastroenterol, Montreal, PQ, Canada
[7] Univ Alberta, Div Gen Internal Med, Edmonton, AB, Canada
[8] McMaster Univ, Farncombe Family Digest Hlth Res Ctr, Hamilton, ON, Canada
[9] British Columbia Childrens Hosp, Div Gastroenterol, Vancouver, BC V6H 3V4, Canada
[10] Univ British Columbia, CFRI, Vancouver, BC V5Z 1M9, Canada
[11] Univ Alberta, Dept Med, Edmonton, AB, Canada
来源
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2012年 / 26卷 / 02期
关键词
Gastric cancer; Helicobacter pylori; Immigrants; Native Canadians; PREVENT GASTRIC-CANCER; RANDOMIZED CONTROLLED-TRIAL; ALASKA NATIVE POPULATION; COST-EFFECTIVENESS; DUODENAL-ULCER; TRIPLE THERAPY; QUADRUPLE THERAPY; UNITED-STATES; ENDOSCOPIC RESECTION; AMERICAN-INDIANS;
D O I
10.1155/2012/174529
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
NL Jones, N Chiba, C Fallone, et al; on behalf of Canadian Helicobacter study group participants. Helicobacter pylori in First Nations and recent immigrant populations in Canada. Can J Gastroenterol 2012;26(2):97-103. The diminishing prevalence of Helicobacter pylori infection among most segments of the Canadian population has led to changes in the etiologies and patterns of associated upper gastrointestinal diseases, including fewer peptic ulcers and their complications. Canadian Aboriginals and recent immigrants are among populations in which the prevalence of H pylori infection remains high and, therefore, the health risks imposed by H pylori remain a significant concern. Population-based strategies for H pylori eradication in groups with a low prevalence of infection are unlikely to be cost effective, but such measures are attractive in groups in which the prevalence rates of infection remain substantial. In addition to a lower prevalence of peptic ulcers and dyspepsia, the public health value of eradication may be particularly important if this leads to a reduction in the prevalence of gastric cancer in high prevalence groups. Therefore The Canadian Helicobacter Study Group held a conference that brought together experts in the field to address these issues, the results of which are reviewed in the present article. Canadians with the highest prevalence of H pylori infection are an appropriate focus for considering the health advantages of eradicating persistent infection. In Canadian communities with a high prevalence of both H pylori and gastric cancer, there remains an opportunity to test the hypothesis that H pylori infection is a treatable risk factor for malignancy.
引用
收藏
页码:97 / 103
页数:7
相关论文
共 76 条
  • [31] EFFECT OF RANITIDINE AND AMOXICILLIN PLUS METRONIDAZOLE ON THE ERADICATION OF HELICOBACTER-PYLORI AND THE RECURRENCE OF DUODENAL-ULCER
    HENTSCHEL, E
    BRANDSTATTER, G
    DRAGOSICS, B
    HIRSCHL, AM
    NEMEC, H
    SCHUTZE, K
    TAUFER, M
    WURZER, H
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (05) : 308 - 312
  • [32] Neglected Infections of Poverty among the Indigenous Peoples of the Arctic
    Hotez, Peter J.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2010, 4 (01):
  • [33] Canadian Helicobacter pylori Consensus Conference
    Hunt, R
    Thomson, ABR
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY, 1998, 12 (01): : 31 - 41
  • [34] Will eradication of Helicobacter pylori infection influence the risk of gastric cancer?
    Hunt, RH
    [J]. AMERICAN JOURNAL OF MEDICINE, 2004, 117 : 86S - 91S
  • [35] Augmented gp130-mediated cytokine signalling accompanies human gastric cancer progression
    Jackson, C. B.
    Judd, L. M.
    Menheniott, T. R.
    Kronborg, I.
    Dow, C.
    Yeomans, N. D.
    Boussioutas, A.
    Robb, L.
    Giraud, A. S.
    [J]. JOURNAL OF PATHOLOGY, 2007, 213 (02) : 140 - 151
  • [36] Johansen Jens Kurt, 2004, Int J Circumpolar Health, V63 Suppl 2, P219
  • [37] KUIPERS EJ, 1995, ALIMENT PHARM THERAP, V9, P59
  • [38] Laine L, 2003, AM J GASTROENTEROL, V98, P562, DOI [10.1016/S0002-9270(02)06010-0, 10.1111/j.1572-0241.2003.t01-1-07288.x]
  • [39] An Empiric Estimate of the Value of Life: Updating the Renal Dialysis Cost-Effectiveness Standard
    Lee, Chris P.
    Chertow, Glenn M.
    Zenios, Stefanos A.
    [J]. VALUE IN HEALTH, 2009, 12 (01) : 80 - 87
  • [40] Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design
    Liou, Jyh-Ming
    Lin, Jaw-Town
    Chang, Chi-Yang
    Chen, Mei-Jyh
    Cheng, Tsu-Yao
    Lee, Yi-Chia
    Chen, Chien-Chuan
    Sheng, Wang-Huei
    Wang, Hsiu-Po
    Wu, Ming-Shiang
    [J]. GUT, 2010, 59 (05) : 572 - 578